Midazolam Patent Expiration

Midazolam was first introduced by Ucb Inc in its drug Nayzilam on May 17, 2019. Other drugs containing Midazolam are Midazolam In 0.9% Sodium Chloride, Midazolam In 0.8% Sodium Chloride. 6 different companies have introduced drugs containing Midazolam.


Midazolam Patents

Given below is the list of patents protecting Midazolam, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Midazolam In 0.9% Sodium Chloride US10966990 Midazolam in flexible bags Jun 20, 2038 Inforlife
Nayzilam US8217033 Methods and compositions for the delivery of a therapeutic agent Jan 18, 2028 Ucb Inc
Nayzilam US8809322 Methods and compositions for the delivery of a therapeutic agent Jan 18, 2028 Ucb Inc
Nayzilam US9289432 Methods and compositions for the delivery of a therapeutic agent Jan 18, 2028 Ucb Inc
Nayzilam US9687495 Methods and systems for the delivery of a therapeutic agent Jan 18, 2028 Ucb Inc



Midazolam's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Midazolam Generic API Manufacturers

Several generic applications have been filed for Midazolam. The first generic version for Midazolam was by Hikma Pharmaceuticals Usa Inc and was approved on Apr 17, 2023. And the latest generic version is by B Braun Medical Inc and was approved on May 1, 2025.

Given below is the list of companies who have filed for Midazolam generic, along with the locations of their manufacturing plants worldwide.